vs
NEPHROS INC（NEPH）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Rocky Mountain Chocolate Factory, Inc.的季度营收约是NEPHROS INC的1.6倍（$7.5M vs $4.7M），NEPHROS INC净利率更高（1.3% vs -2.1%，领先3.4%），NEPHROS INC同比增速更快（22.2% vs -4.4%），过去两年NEPHROS INC的营收复合增速更高（15.9% vs 1.9%）
Nephros Inc是一家医疗科技企业，主要研发和销售高性能净水系统、感染防控产品及肾脏护理解决方案，产品主要供给北美地区的医院、透析诊所以及长期护理机构，用于降低水传播病原体风险，提升患者诊疗效果。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
NEPH vs RMCF — 直观对比
营收规模更大
RMCF
是对方的1.6倍
$4.7M
营收增速更快
NEPH
高出26.6%
-4.4%
净利率更高
NEPH
高出3.4%
-2.1%
两年增速更快
NEPH
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $4.7M | $7.5M |
| 净利润 | $62.0K | $-155.0K |
| 毛利率 | 58.4% | 34.0% |
| 营业利润率 | 0.4% | 1.1% |
| 净利率 | 1.3% | -2.1% |
| 营收同比 | 22.2% | -4.4% |
| 净利润同比 | -82.2% | 81.7% |
| 每股收益（稀释后） | $0.01 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEPHRMCF
| Q4 25 | $4.7M | $7.5M | ||
| Q3 25 | $4.8M | $6.8M | ||
| Q2 25 | $4.4M | $6.4M | ||
| Q1 25 | $4.9M | $8.9M | ||
| Q4 24 | $3.9M | $7.9M | ||
| Q3 24 | $3.5M | $6.4M | ||
| Q2 24 | $3.3M | $6.4M | ||
| Q1 24 | $3.5M | $7.3M |
净利润NEPHRMCF
| Q4 25 | $62.0K | $-155.0K | ||
| Q3 25 | $337.0K | $-662.0K | ||
| Q2 25 | $237.0K | $-324.0K | ||
| Q1 25 | $558.0K | $-2.9M | ||
| Q4 24 | $349.0K | $-847.0K | ||
| Q3 24 | $183.0K | $-722.0K | ||
| Q2 24 | $-289.0K | $-1.7M | ||
| Q1 24 | $-169.0K | $-1.6M |
毛利率NEPHRMCF
| Q4 25 | 58.4% | 34.0% | ||
| Q3 25 | 61.2% | 23.6% | ||
| Q2 25 | 63.2% | 31.1% | ||
| Q1 25 | 64.7% | 10.8% | ||
| Q4 24 | 64.0% | 23.4% | ||
| Q3 24 | 61.1% | 31.8% | ||
| Q2 24 | 58.8% | 12.8% | ||
| Q1 24 | 62.1% | 24.3% |
营业利润率NEPHRMCF
| Q4 25 | 0.4% | 1.1% | ||
| Q3 25 | 6.6% | -7.0% | ||
| Q2 25 | 5.6% | -2.3% | ||
| Q1 25 | 11.6% | -30.3% | ||
| Q4 24 | 8.2% | -8.9% | ||
| Q3 24 | 5.9% | -14.3% | ||
| Q2 24 | -9.7% | -25.4% | ||
| Q1 24 | -5.7% | -21.7% |
净利率NEPHRMCF
| Q4 25 | 1.3% | -2.1% | ||
| Q3 25 | 7.1% | -9.7% | ||
| Q2 25 | 5.4% | -5.1% | ||
| Q1 25 | 11.4% | -32.5% | ||
| Q4 24 | 9.0% | -10.7% | ||
| Q3 24 | 5.2% | -11.3% | ||
| Q2 24 | -8.9% | -25.9% | ||
| Q1 24 | -4.8% | -21.9% |
每股收益（稀释后）NEPHRMCF
| Q4 25 | $0.01 | $-0.02 | ||
| Q3 25 | $0.03 | $-0.09 | ||
| Q2 25 | $0.02 | $-0.04 | ||
| Q1 25 | $0.05 | $-0.38 | ||
| Q4 24 | $0.04 | $-0.11 | ||
| Q3 24 | $0.02 | $-0.11 | ||
| Q2 24 | $-0.03 | $-0.26 | ||
| Q1 24 | $-0.02 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.4M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $10.2M | $6.0M |
| 总资产 | $13.6M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEPHRMCF
| Q4 25 | $5.4M | $641.0K | ||
| Q3 25 | $5.2M | $2.0M | ||
| Q2 25 | $5.1M | $893.0K | ||
| Q1 25 | $4.1M | $720.0K | ||
| Q4 24 | $3.8M | $1.1M | ||
| Q3 24 | $2.5M | $973.0K | ||
| Q2 24 | $3.1M | $637.0K | ||
| Q1 24 | $3.6M | $2.1M |
股东权益NEPHRMCF
| Q4 25 | $10.2M | $6.0M | ||
| Q3 25 | $10.0M | $6.1M | ||
| Q2 25 | $9.6M | $6.7M | ||
| Q1 25 | $9.3M | $7.0M | ||
| Q4 24 | $8.6M | $9.8M | ||
| Q3 24 | $8.2M | $10.5M | ||
| Q2 24 | $7.9M | $9.0M | ||
| Q1 24 | $8.2M | $10.6M |
总资产NEPHRMCF
| Q4 25 | $13.6M | $20.7M | ||
| Q3 25 | $13.2M | $22.3M | ||
| Q2 25 | $12.2M | $20.1M | ||
| Q1 25 | $11.8M | $21.2M | ||
| Q4 24 | $11.2M | $21.6M | ||
| Q3 24 | $10.4M | $21.1M | ||
| Q2 24 | $11.1M | $19.0M | ||
| Q1 24 | $11.4M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $230.0K | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-1.3M |
| 自由现金流率自由现金流/营收 | — | -16.9% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 3.71× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NEPHRMCF
| Q4 25 | $230.0K | $-1.2M | ||
| Q3 25 | $99.0K | $-488.0K | ||
| Q2 25 | $994.0K | $350.0K | ||
| Q1 25 | $322.0K | $1.2M | ||
| Q4 24 | $1.3M | $-2.1M | ||
| Q3 24 | $-623.0K | $-3.5M | ||
| Q2 24 | $-501.0K | $-2.2M | ||
| Q1 24 | $-672.0K | $129.0K |
自由现金流NEPHRMCF
| Q4 25 | — | $-1.3M | ||
| Q3 25 | — | $-544.0K | ||
| Q2 25 | — | $182.0K | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-4.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $-352.3K |
自由现金流率NEPHRMCF
| Q4 25 | — | -16.9% | ||
| Q3 25 | — | -8.0% | ||
| Q2 25 | — | 2.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -72.6% | ||
| Q2 24 | — | -40.2% | ||
| Q1 24 | — | -4.9% |
资本支出强度NEPHRMCF
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | — | 6.5% | ||
| Q1 24 | — | 6.6% |
现金转化率NEPHRMCF
| Q4 25 | 3.71× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 4.19× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 3.74× | — | ||
| Q3 24 | -3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEPH
| Products | $4.6M | 98% |
| Other | $108.0K | 2% |
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
